Myocardial hypertrophy overrides the angiogenic response to hypoxia

Yeong-Hoon Choi1, Douglas B Cowan, Meena Nathan

  • 1Department of Cardiac Surgery, Children's Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA. yh.choi@uk-koeln.de

Plos One
|December 30, 2008
PubMed

Insights

In hypertrophied hearts, hypoxia fails to stimulate new blood vessel growth (angiogenesis). This blunted response is linked to altered signaling pathways involving hypoxia-inducible factors (HIF) and vascular endothelial growth factor receptors (VEGFR).

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Developmental Biology

Background:

  • Cyanosis and myocardial hypertrophy often coexist, with hypoxia potentially inducing angiogenesis via HIF and VEGF pathways.
  • Pressure overload hypertrophy typically impairs pro-angiogenic signaling and reduces myocardial capillary density.
  • This study investigates the blunted pro-angiogenic response to cyanosis in hypertrophied hearts.

Purpose of the Study:

  • To investigate the hypothesis that the physiological pro-angiogenic response to cyanosis in hypertrophied myocardium is blunted.
  • To examine the role of differential hypoxia-inducible factor (HIF) and vascular endothelial growth factor (VEGF) signaling in this blunted response.
  • To determine the impact on myocardial angiogenesis and capillary density.

Main Methods:

  • Newborn rabbits underwent aortic banding to induce hypertrophy and were exposed to hypoxia (FiO2 = 0.12).
  • Systemic cyanosis was confirmed, and myocardial tissue was analyzed for hypoxia markers.
  • HIF-1alpha, HIF-2alpha, VEGF, VEGFR-1, and VEGFR-2 levels, along with DNA-binding activity and capillary density, were assessed.

Main Results:

  • Non-hypertrophied hearts responded to hypoxia with increased capillary density.
  • Hypertrophied hearts exposed to hypoxia showed no increase in angiogenesis, indicating a blunted response.
  • This blunted response was associated with lower HIF-2alpha and VEGFR-2, and increased HIF-1alpha activity and VEGFR-1 expression.

Conclusions:

  • Hypoxia-stimulated myocardial angiogenesis appears to require HIF-2alpha and VEGFR-2.
  • In infant rabbit hearts with pressure overload hypertrophy, the pro-angiogenic response to hypoxia is uncoupled.
  • Altered HIF-mediated signaling and VEGFR subtype expression contribute to this uncoupling.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...